News Releases

MDxHealth to Present at November 2015 Investor Conferences

IRVINE, Calif. and HERSTAL, Belgium, Nov. 4, 2015 /PRNewswire/ -- MDxHealth SA (Euronext: MDXH.BR), today announced that Dr. Jan Groen, Chief Executive Officer, will present at the following investor conferences this month:

  • 4th KBC Securities Benelux Biotech & Healthcare Seminar
    • Date: Tuesday, November 10, 2015
    • Location: Convene Conference Center, 101 Park Avenue, New York
  • 9th Annual Canaccord Genuity Medical Technology & Diagnostics Forum
    • Date: Thursday, November 19, 2015, 4:00 PM Eastern Time
    • Location: Westin Grand Central, New York City
    • A live webcast of this presentation will be available at the Investor tab of the MDxHealth website at

About MDxHealth
MDxHealth is a multinational healthcare company that provides actionable epigenetic and molecular information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation (epigenetic) technology and assist physicians with the diagnosis of cancer, prognosis of recurrence risk, and prediction of response to a specific therapy. For more information visit and follow us on Twitter at:

This press release contains forward-looking statements and estimates with respect to the anticipated future performance of MDxHealth and the market in which it operates. Such statements and estimates are based on assumptions and assessments of known and unknown risks, uncertainties and other factors, which were deemed reasonable but may not prove to be correct. Actual events are difficult to predict, may depend upon factors that are beyond the company's control, and may turn out to be materially different. MDxHealth expressly disclaims any obligation to update any such forward-looking statements in this release to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based unless required by law or regulation.  This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of MDxHealth in any jurisdiction. No securities of MDxHealth may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. securities laws.

NOTE: The MDxHealth logo, MDxHealth, ConfirmMDx, SelectMDx and PredictMDx are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners.


For further information: Dr. Jan Groen, CEO, MDxHealth, US: +1 949 812 6979, BE: +32 4 364 20 70, | Amber Fennell, Chris Welsh, Hendrik Thys (PR & IR), Consilium Strategic Communications, UK: +44 20 3709 5701, Cell: + 44 7739658783, | Melody Carey (U.S. IR), Rx Communications Group LLC, US: +1 917 322 2571,